Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?

The First Trust Consumer Staples AlphaDEX ETF (FXG), a $284.05 million smart beta fund launched in 2007, provides concentrated exposure to the consumer staples sector using an AlphaDEX screening methodology. While it aims for alpha and carries a medium risk profile with a 1.03% YTD return and a -3.4% 12-month performance, its 0.62% expense ratio is notably higher than larger, market-cap weighted alternatives such as Vanguard Consumer Staples ETF (VDC) at 0.09% and Consumer Staples Select Sector SPDR ETF (XLP) at 0.08%. This positions FXG as a higher-cost, more concentrated option for investors seeking specific factor exposure within consumer staples, contrasting with more diversified, lower-cost index strategies.

Analysis

The First Trust Consumer Staples AlphaDEX ETF (FXG) is a smart beta fund that attempts to generate alpha through its proprietary StrataQuant screening methodology. However, its performance has been weak, posting a 1.03% year-to-date return and a negative 3.4% return over the last 12 months as of September 11, 2025. A significant headwind for the fund is its high expense ratio of 0.62%, which stands in stark contrast to the fees of its much larger, market-cap weighted peers, Vanguard's VDC (0.09%) and State Street's XLP (0.08%). While FXG offers a lower volatility profile with a beta of 0.57, its structure is more concentrated than peers, with 41 holdings where the top ten account for 40.2% of its $284.05 million in assets. This combination of high costs, recent underperformance, and a concentrated, non-traditional weighting scheme positions FXG as a higher-risk proposition for investors banking on a specific factor strategy to outperform, which it has not recently achieved.

Key Decisions for Investors

• Investors should critically evaluate if the fund's smart beta strategy justifies its high 0.62% expense ratio, which significantly erodes potential alpha compared to passive alternatives VDC and XLP with fees below 0.10%.
• Given the fund's negative 12-month return of -3.4%, it is prudent to question the current efficacy of the AlphaDEX screening methodology and consider whether a passive, market-cap weighted approach offers superior risk-adjusted returns in the consumer staples sector.
• Potential investors should analyze the fund's concentrated portfolio to determine if its specific factor exposures, such as the 4.56% weighting in Pilgrim's Pride, align with their investment thesis, as this deviates significantly from broader sector benchmarks.
• For those seeking defensive consumer staples exposure, cheaper and more diversified ETFs like VDC and XLP appear to be lower-risk options, as FXG's performance and fee structure do not currently support a premium for its active selection strategy.